Which peptides are FDA-approved?
Short answer
58 of the 116 profiles here are FDA-approved, according to the U.S. labels and FDA records their profiles cite. Seven more had an FDA approval that was later withdrawn or whose products are all discontinued; they are listed separately.
Each entry below quotes its profile and links to the full answer there.
Metabolic and weight 13
FDA-approved. Drugs@FDA lists Trulicity with an original approval date of September 18, 2014. The label carries a boxed warning about thyroid C-cell tumors in rats.1,2
Is dulaglutide FDA-approved? · Dulaglutide vs Semaglutide · Dulaglutide vs Tirzepatide
FDA-approved as Victoza, Saxenda and generic versions15,16,17,18
FDA-approved. Drugs@FDA lists Victoza (first approved January 25, 2010), Saxenda (December 23, 2014) and generic liraglutide applications, the first approved December 23, 2024. The label carries a boxed warning about thyroid C-cell tumors in rodents.15,16,17,18
Is liraglutide FDA-approved? · Liraglutide vs Semaglutide · Liraglutide vs Tirzepatide
Metreleptin
Not a peptide: a protein, larger than a peptide, often looked up alongside peptides
Orforglipron
Not a peptide: a small molecule often looked up alongside peptides
FDA-approved as Foundayo for weight reduction in adults24,25
FDA-approved. Drugs@FDA lists Foundayo with an original approval date of April 1, 2026. The label has a boxed warning about the risk of thyroid C-cell tumors.24,25
Is orforglipron FDA-approved? · Orforglipron vs Semaglutide · Orforglipron vs Tirzepatide
FDA-approved as Ozempic, Rybelsus and Wegovy28,29,30,31
FDA-approved. Drugs@FDA lists Ozempic (first approved December 5, 2017), Rybelsus (September 20, 2019) and Wegovy (June 4, 2021). The Wegovy label carries a boxed warning about thyroid C-cell tumors seen in rodents.28,29,30,31
Is semaglutide FDA-approved? · Semaglutide vs Tirzepatide · Semaglutide vs Retatrutide
FDA-approved as Egrifta for HIV-associated abdominal fat34,35
FDA-approved. Drugs@FDA lists Egrifta (first approved November 10, 2010), and the label covers reducing excess abdominal fat in adults with HIV and lipodystrophy. The cited label has no boxed warning.34,35
Is tesamorelin FDA-approved? · AOD-9604 vs Tesamorelin · Sermorelin vs Tesamorelin
FDA-approved as Mounjaro and Zepbound36,37,38
FDA-approved. Drugs@FDA lists Mounjaro (first approved May 13, 2022) and Zepbound (November 8, 2023). The Zepbound label carries a boxed warning about thyroid C-cell tumors seen in rats.36,37,38
Is tirzepatide FDA-approved? · Semaglutide vs Tirzepatide · Tirzepatide vs Retatrutide
Heart and blood vessels 3
FDA-approved as Vasostrict for vasodilatory shock43,44
FDA-approved. Drugs@FDA lists Vasostrict with an original approval date of April 17, 2014. The cited label has no boxed warning.43,44
Is vasopressin FDA-approved? · Oxytocin vs Vasopressin · Desmopressin vs Vasopressin
Liver 1
Hormones 9
Bone and growth 5
FDA-approved as Tymlos for osteoporosis70,71
FDA-approved. Drugs@FDA lists Tymlos with an original approval date of April 28, 2017. The cited label has no boxed warning; its warnings include a risk of osteosarcoma seen in rats.70,71
Is abaloparatide FDA-approved? · Teriparatide vs Abaloparatide
Mecasermin
Not a peptide: a protein, larger than a peptide, often looked up alongside peptides
FDA-approved as Forteo and other teriparatide products76,77,78,79,80,81
FDA-approved. Drugs@FDA lists Forteo with an original approval date of November 26, 2002, and later teriparatide applications, the most recent approved on October 23, 2026. The cited label has no boxed warning.76,77,78,79,80,81
Is teriparatide FDA-approved? · Teriparatide vs Abaloparatide
Gut and digestion 4
Brain, nerves and sleep 3
Glatiramer acetate
Not a single peptide: a mixture often looked up alongside peptides
Skin 2
FDA-approved as Scenesse for erythropoietic protoporphyria98,99
FDA-approved. Drugs@FDA lists Scenesse with an original approval date of October 8, 2019, and the label limits its use to adults with EPP. The cited label has no boxed warning.98,99
Is afamelanotide FDA-approved? · Melanotan II vs Afamelanotide
Sexual and reproductive health 3
FDA-approved as Vyleesi for HSDD in premenopausal women102,103
FDA-approved. Drugs@FDA lists Vyleesi with an original approval date of June 21, 2019, for HSDD in premenopausal women. The cited label has no boxed warning.102,103
Is bremelanotide FDA-approved? · Melanotan II vs Bremelanotide
Inflammation and immune 2
FDA-approved as Empaveli for PNH and two complement-driven kidney diseases110,111
FDA-approved. Drugs@FDA lists Empaveli, NDA 215014, approved May 14, 2021, and a second pegcetacoplan product, Syfovre, NDA 217171, approved February 17, 2023. The Empaveli label has a boxed warning about serious infections.110,111,112
Cancer 8
FDA-approved as Lupron, Eligard, Vobrig and other leuprolide products121,122,123,124,125,126
FDA-approved. Drugs@FDA lists Lupron with an original approval date of April 9, 1985, and Eligard with one of January 23, 2002, among many leuprolide applications. The cited Eligard label has no boxed warning.121,122,124
Is leuprolide FDA-approved? · Leuprolide vs Triptorelin · Goserelin vs Leuprolide
FDA-approved as Lutathera for gastroenteropancreatic neuroendocrine tumors127,128
FDA-approved. Drugs@FDA lists Lutathera, NDA 208700, with an original approval date of January 26, 2018, and a second product, Bexlutry, NDA 218525, approved September 14, 2026. The cited label has no boxed warning.127,128,129
Muscle 2
Infections 2
Other areas 1
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Citations
Sources
Numbered markers in the text point here. Each link opens the original public record.
- 1TRULICITY (dulaglutide) injection, solution · SPL version 62 · published 2026-08-10 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026
- 2Drugs@FDA application BLA125469 · original submission status AP · 2014-09-18 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 3Exenatide injection · SPL version 17 · published 2026-06-30 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 4Drugs@FDA application NDA021773 · original submission status AP · 2005-04-28 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 5Drugs@FDA application NDA022200 · original submission status AP · 2012-01-27 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 6Drugs@FDA application NDA209210 · original submission status AP · 2017-10-20 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 7Drugs@FDA application ANDA206697 · original submission status AP · 2024-11-19 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 8GVOKE VIALDX (glucagon) injection, solution · SPL version 2 · published 2026-07-09 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 9Drugs@FDA application NDA012122 · original submission status AP · 1960-11-14 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 10Drugs@FDA application NDA210134 · original submission status AP · 2019-07-24 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 11Drugs@FDA application NDA212097 · original submission status AP · 2019-09-10 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 12LANGLARA (insulin glargine-aldy) injection, solution · SPL version 5 · published 2026-07-08 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 13Drugs@FDA application BLA761412 · original submission status AP · 2026-04-29 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 14Langlara (insulin glargine-aldy): BLA 761412 approval letter, April 29, 2026 ↗
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
- 15Liraglutide injection, solution · SPL version 6 · published 2026-07-14 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 16Drugs@FDA application NDA022341 · original submission status AP · 2010-01-25 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 17Drugs@FDA application NDA206321 · original submission status AP · 2014-12-23 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 18Drugs@FDA application ANDA215503 · original submission status AP · 2024-12-23 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 19Drugs@FDA application BLA208471 · original submission status AP · 2016-07-27 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 20ADLYXIN, revised November 2024: U.S. prescribing information ↗
U.S. Food and Drug Administration · Official source · Source checked September 15, 2026
- 21SOLIQUA 100/33 (insulin glargine and lixisenatide) injection · SPL version 25 · published 2026-03-20 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 22Drugs@FDA: MYALEPT (metreleptin), application 125390 · original approval February 24, 2014 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 23MYALEPT (metreleptin) for injection · SPL version 18 · published 2025-03-10 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 24Drugs@FDA: FOUNDAYO (orforglipron calcium), NDA 220934 · original approval April 1, 2026 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 25FOUNDAYO (orforglipron) tablet, film coated · SPL version 10 · published 2026-08-13 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 26SYMLINPEN (pramlintide acetate) injection · SPL version 18 · published 2024-08-20 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 27Drugs@FDA application NDA021332 · original submission status AP · 2005-03-16 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 28WEGOVY (semaglutide) injection and tablet · SPL version 19 · published 2026-06-30 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 29Drugs@FDA application NDA209637 · original submission status AP · 2017-12-05 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 30Drugs@FDA application NDA213051 · original submission status AP · 2019-09-20 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 31Drugs@FDA application NDA215256 · original submission status AP · 2021-06-04 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 32IMCIVREE (setmelanotide) solution · SPL version 14 · published 2026-04-02 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 33Drugs@FDA application NDA213793 · original submission status AP · 2020-11-25 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 34EGRIFTA SV (tesamorelin) kit · SPL version 9 · published 2026-07-31 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026
- 35Drugs@FDA application BLA022505 · original submission status AP · 2010-11-10 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 36ZEPBOUND (tirzepatide) injection · SPL version 40 · published 2026-09-02 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026
- 37Drugs@FDA application NDA215866 · original submission status AP · 2022-05-13 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 38Drugs@FDA application NDA217806 · original submission status AP · 2023-11-08 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 39Bivalirudin for injection, powder, lyophilized, for solution (Sandoz Inc.) · SPL version 5 · published 2026-07-29 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 40Drugs@FDA: ANGIOMAX (bivalirudin), NDA 020873 · original approval December 15, 2000 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 41Eptifibatide injection (Baxter Healthcare Company) · SPL version 13 · published 2026-05-21 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 42Drugs@FDA: INTEGRILIN (eptifibatide), NDA 020718 · original approval May 18, 1998 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 43VASOSTRICT (vasopressin) injection · SPL version 49 · published 2026-05-18 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 44Drugs@FDA: VASOSTRICT (vasopressin), NDA 204485 · original approval April 17, 2014 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 45TERLIVAZ (terlipressin) for injection · SPL version 8 · published 2026-10-26 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 46Drugs@FDA: TERLIVAZ (terlipressin acetate), NDA 022231 · original approval September 14, 2022 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 47DDAVP (desmopressin acetate) tablet · SPL version 7 · published 2025-12-10 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 48Drugs@FDA: DDAVP (desmopressin acetate), NDA 019955 · original approval September 6, 1995 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 49PARSABIV (etelcalcetide) injection, solution · SPL version 15 · published 2026-03-16 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 50Drugs@FDA: PARSABIV (etelcalcetide), NDA 208325 · original approval February 7, 2017 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 51SUPPRELIN LA (histrelin acetate) implant · SPL version 38 · published 2025-09-29 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 52Drugs@FDA: SUPPRELIN LA (histrelin acetate), NDA 022058 · original approval May 3, 2007 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 53Lanreotide acetate injection · SPL version 3 · published 2025-06-02 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 54Drugs@FDA application NDA022074 · original submission status AP · 2007-08-30 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 55Drugs@FDA application NDA215395 · original submission status AP · 2021-12-17 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 56Drugs@FDA application ANDA217193 · original submission status AP · 2024-05-21 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 57SYNAREL (nafarelin acetate) nasal solution · SPL version 23 · published 2026-03-10 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 58Drugs@FDA: SYNAREL (nafarelin acetate), NDA 019886 · original approval February 13, 1990 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 59Octreotide acetate injection, solution · SPL version 2 · published 2026-02-02 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 60Drugs@FDA application NDA019667 · original submission status AP · 1988-10-21 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 61Drugs@FDA application NDA021008 · original submission status AP · 1998-11-25 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 62Drugs@FDA application NDA208232 · original submission status AP · 2020-06-26 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 63Drugs@FDA application NDA213224 · original submission status AP · 2024-09-27 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 64PITOCIN (oxytocin) injection · SPL version 15 · published 2026-05-21 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 65Drugs@FDA: PITOCIN (oxytocin), NDA 018261 · original approval November 19, 1980 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 66YORVIPATH (palopegteriparatide) injection, solution · SPL version 10 · published 2026-11-09 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 67Drugs@FDA: YORVIPATH (palopegteriparatide), NDA 216490 · original approval August 9, 2024 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 68SIGNIFOR (pasireotide) injection · SPL version 20 · published 2026-02-18 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 69Drugs@FDA: SIGNIFOR (pasireotide diaspartate), NDA 200677 · original approval December 14, 2012 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 70TYMLOS (abaloparatide) injection, solution · SPL version 19 · published 2026-08-17 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026
- 71Drugs@FDA application NDA208743 · original submission status AP · 2017-04-28 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 72MIACALCIN (calcitonin salmon) injection, solution · SPL version 9 · published 2026-06-19 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 73Drugs@FDA: MIACALCIN (calcitonin salmon), NDA 017808 · original approval July 3, 1986 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 74Drugs@FDA: INCRELEX (mecasermin [rDNA origin]), application 021839 · original approval August 30, 2005 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 75INCRELEX (mecasermin) injection · SPL version 4 · published 2025-11-17 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 76Teriparatide injection, solution · SPL version 10 · published 2026-09-21 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 77Drugs@FDA application NDA021318 · original submission status AP · 2002-11-26 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 78Drugs@FDA application NDA211939 · original submission status AP · 2019-10-04 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 79Drugs@FDA application ANDA211097 · original submission status AP · 2023-11-16 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 80Drugs@FDA application NDA218771 · original submission status AP · 2024-06-04 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 81Drugs@FDA application ANDA214412 · original submission status AP · 2026-10-23 · dataset 2026-11-13 ↗
Drugs@FDA via openFDA · Official source · Source checked November 15, 2026
- 82VOXZOGO (vosoritide) kit · SPL version 16 · published 2025-11-26 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 83Drugs@FDA application NDA214938 · original submission status AP · 2021-11-19 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 84LINZESS (linaclotide) capsule · SPL version 39 · published 2026-06-01 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 85Drugs@FDA application NDA202811 · original submission status AP · 2012-08-30 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 86TRULANCE (plecanatide) tablet · SPL version 15 · published 2024-04-05 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 87Drugs@FDA application NDA208745 · original submission status AP · 2017-01-19 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 88CHIRHOSTIM (human secretin) for injection · SPL version 20251008 · published 2025-11-17 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 89Drugs@FDA: CHIRHOSTIM (secretin synthetic human), NDA 021256 · original approval April 9, 2004 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 90GATTEX (teduglutide) kit · SPL version 20 · published 2025-09-18 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 91Drugs@FDA: GATTEX (teduglutide), NDA 203441 · original approval December 21, 2012 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 92Drugs@FDA: COPAXONE (glatiramer acetate), NDA 020622 · original approval December 20, 1996 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 93COPAXONE (glatiramer acetate injection) · SPL version 36 · published 2026-06-26 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 94DAYBUE (trofinetide) solution; DAYBUE STIX (trofinetide) for solution · SPL version 12 · published 2026-09-11 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 95Drugs@FDA: DAYBUE (trofinetide), NDA 217026 · original approval March 10, 2023 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 96PRIALT (ziconotide acetate) injection, solution · SPL version 6 · published 2025-07-14 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 97Drugs@FDA application NDA021060 · original submission status AP · 2004-12-28 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 98SCENESSE (afamelanotide) implant · SPL version 11 · published 2026-05-13 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 99Drugs@FDA application NDA210797 · original submission status AP · 2019-10-08 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 100KORSUVA (difelikefalin) injection, solution · SPL version 9 · published 2025-09-01 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 101Drugs@FDA: KORSUVA (difelikefalin acetate), NDA 214916 · original approval August 23, 2021 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 102VYLEESI (bremelanotide) injection · SPL version 1 · published 2025-11-18 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 103Drugs@FDA application NDA210557 · original submission status AP · 2019-06-21 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 104CETROTIDE (cetrorelix acetate) kit · SPL version 18 · published 2025-09-29 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 105Drugs@FDA: CETROTIDE (cetrorelix acetate), NDA 021197 · original approval August 11, 2000 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 106Ganirelix acetate injection, solution (Organon LLC) · SPL version 10 · published 2026-10-12 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 107Drugs@FDA: Ganirelix acetate (Organon), NDA 021057 · original approval July 29, 1999 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 108FIRAZYR (icatibant acetate) injection, solution · SPL version 19 · published 2025-07-17 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 109Drugs@FDA: FIRAZYR (icatibant acetate), NDA 022150 · original approval August 25, 2011 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 110EMPAVELI (pegcetacoplan) injection · SPL version 14 · published 2026-08-25 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 111Drugs@FDA: EMPAVELI (pegcetacoplan), NDA 215014 · original approval May 14, 2021 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 112Drugs@FDA: SYFOVRE (pegcetacoplan), NDA 217171 · original approval February 17, 2023 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 113Drugs@FDA: KYPROLIS (carfilzomib), NDA 202714 · original approval July 20, 2012 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 114KYPROLIS (carfilzomib) for injection · SPL version 59 · published 2025-06-26 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 115FIRMAGON (degarelix) kit · SPL version 18 · published 2024-02-01 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 116Drugs@FDA: FIRMAGON (degarelix acetate), NDA 022201 · original approval December 24, 2008 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 117Drugs@FDA: NETSPOT (gallium dotatate Ga-68), NDA 208547 · original approval June 1, 2016 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 118NETSPOT (kit for the preparation of gallium Ga 68 dotatate injection) · SPL version 23 · published 2026-07-07 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 119ZOLADEX (goserelin) implant · SPL version 9 · published 2026-03-26 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 120Drugs@FDA: ZOLADEX (goserelin acetate), NDA 019726 · original approval December 29, 1989 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 121ELIGARD (leuprolide acetate) injection, suspension, extended release · SPL version 19 · published 2026-05-11 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 122Drugs@FDA application NDA019010 · original submission status AP · 1985-04-09 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 123Drugs@FDA application NDA019732 · original submission status AP · 1989-01-26 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 124Drugs@FDA application NDA021343 · original submission status AP · 2002-01-23 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 125Vobrig (leuprolide acetate): NDA 213225 approval letter, August 26, 2026 ↗
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
- 126Drugs@FDA application NDA213225 · original submission status AP · 2026-08-26 · dataset 2026-11-13 ↗
Drugs@FDA via openFDA · Official source · Source checked November 15, 2026
- 127LUTATHERA (lutetium Lu 177 dotatate) injection · SPL version 12 · published 2026-01-16 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 128Drugs@FDA: LUTATHERA (lutetium Lu-177 dotatate), NDA 208700 · original approval January 26, 2018 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 129Drugs@FDA: BEXLUTRY (lutetium Lu-177 dotatate), NDA 218525 · original approval September 14, 2026 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 130APHEXDA (motixafortide) for injection · SPL version 3 · published 2026-10-19 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 131Drugs@FDA: APHEXDA (motixafortide acetate), NDA 217159 · original approval September 8, 2023 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 132TRELSTAR (triptorelin pamoate) kit · SPL version 20 · published 2026-07-10 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 133Drugs@FDA: TRELSTAR (triptorelin pamoate), NDA 020715 · original approval June 15, 2000 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 134Forzinity (elamipretide): NDA 215244 accelerated approval letter, September 19, 2025 ↗
U.S. Food and Drug Administration · Official source · Source checked September 15, 2026
- 135FORZINITY, revised September 2025: U.S. prescribing information ↗
U.S. Food and Drug Administration · Official source · Source checked September 15, 2026
- 136ZILBRYSQ (zilucoplan) injection, solution · SPL version 13 · published 2026-02-05 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 137Drugs@FDA: ZILBRYSQ (zilucoplan sodium), NDA 216834 · original approval October 17, 2023 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 138Drugs@FDA: DALVANCE (dalbavancin hydrochloride), NDA 021883 · original approval May 23, 2014 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 139DALVANCE (dalbavancin) for injection · SPL version 29 · published 2025-11-17 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 140CUBICIN RF (daptomycin) injection, powder, lyophilized, for solution · SPL version 22 · published 2025-06-20 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 141Drugs@FDA: CUBICIN and CUBICIN RF (daptomycin), NDA 021572 · original approval September 12, 2003 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 142MIMRYLO (rusfertide) kit · SPL version 5 · published 2026-11-11 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 143Drugs@FDA: MIMRYLO (rusfertide acetate), NDA 220605 · original approval August 28, 2026 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026